BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1023 related articles for article (PubMed ID: 1751545)

  • 1. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.
    Angel P; Karin M
    Biochim Biophys Acta; 1991 Dec; 1072(2-3):129-57. PubMed ID: 1751545
    [No Abstract]   [Full Text] [Related]  

  • 2. Fos and Jun: inducible transcription factors regulating growth of normal and transformed cells.
    Holt J
    Cancer Treat Res; 1992; 63():301-11. PubMed ID: 1363363
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M; Bister K
    Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-fos proto-oncogene regulation and function.
    Piechaczyk M; Blanchard JM
    Crit Rev Oncol Hematol; 1994 Oct; 17(2):93-131. PubMed ID: 7818789
    [No Abstract]   [Full Text] [Related]  

  • 5. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.
    Kerppola TK; Luk D; Curran T
    Mol Cell Biol; 1993 Jun; 13(6):3782-91. PubMed ID: 8497279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
    Chatton B; Bocco JL; Goetz J; Gaire M; Lutz Y; Kedinger C
    Oncogene; 1994 Feb; 9(2):375-85. PubMed ID: 8290251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive regulation of the skeletal alpha-actin gene by Fos and Jun in cardiac myocytes.
    Bishopric NH; Jayasena V; Webster KA
    J Biol Chem; 1992 Dec; 267(35):25535-40. PubMed ID: 1460048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
    Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
    Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent induction of c-fos and c-jun expression by asbestos.
    Heintz NH; Janssen YM; Mossman BT
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3299-303. PubMed ID: 8386370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encounters with Fos and Jun on the road to AP-1.
    Abate C; Curran T
    Semin Cancer Biol; 1990 Feb; 1(1):19-26. PubMed ID: 2133107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional dissection of AP-1 transcription factors using the Gal4 adaptor assay.
    Smith SE; Bohmann D
    Cell Growth Differ; 1992 Aug; 3(8):523-9. PubMed ID: 1390338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Jun/c-Fos complex in laryngeal squamous cell carcinoma.
    Tsiambas E; Mastronikolis N; P Fotiades P; Kyrodimos E; Chrysovergis A; Papanikolaou V; Mastronikolis S; Peschos D; Roukas D; Ragos V
    J BUON; 2020; 25(2):618-620. PubMed ID: 32521843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells.
    Bernstein LR; Ben-Ari ET; Simek SL; Colburn NH
    Environ Health Perspect; 1991 Jun; 93():111-9. PubMed ID: 1773784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine withdrawal up-regulates c-Fos transcription in pheochromocytoma cells.
    Ichino N; Ishiguro H; Yamada K; Nishii K; Sawada H; Nagatsu T
    Neurosci Res; 1999 Oct; 35(1):63-9. PubMed ID: 10555165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of c-Fos and c-Jun redox-dependent DNA binding activity.
    Xanthoudakis S; Curran T
    Methods Enzymol; 1994; 234():163-74. PubMed ID: 7808290
    [No Abstract]   [Full Text] [Related]  

  • 17. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
    Petz LN; Ziegler YS; Schultz JR; Nardulli AM
    Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity.
    Hawker KL; Pintzas A; Hennigan RF; Gillespie DA; Ozanne BW
    J Virol; 1993 Sep; 67(9):5487-95. PubMed ID: 8350408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast GCN4 as a probe for oncogenesis by AP-1 transcription factors: transcriptional activation through AP-1 sites is not sufficient for cellular transformation.
    Oliviero S; Robinson GS; Struhl K; Spiegelman BM
    Genes Dev; 1992 Sep; 6(9):1799-809. PubMed ID: 1516834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.